2025年韩国血液学会国际会议/第65届年会

◆ 会议时间：2025年3月27-29日
◆ 会议地点：韩国 首尔

◆ 会议简介：

2025年韩国血液学会国际会议/第66届年会(ICKSH2025)将于2025年3月27-29日在韩国首尔举行，会议由韩国血液学会(KSH)主办，预计有来自40多个国家的1300多名与会者参会。大会科学计划包括如良性血液疾病，各种类型的血液系统恶性肿瘤，凝血/血栓形成相关疾病以及输血医学等主题。

韩国血液学会(KSH)成立于1958年，其宗旨是宣促进血液和造血及相关生理和病理现象的研究，现拥有约1500名成员，包括医师、科学家、护士和药剂师等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

ICKSH 2025
Korean Society of Hematology (KSH) International Conference & 66th Annual Meeting
Date: March 27-29, 2025
Venue: Seoul, Korea

摘要征集：

• Deadline for Abstract Submission: December 20, 2024
• Notification of Abstract Acceptance: January 10, 2025

点此提交摘要>>>Submit Abstract>>>

ABSTRACT CATEGORY

• Acute Lymphoblastic Leukemia
• Lymphoma
• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Platelet/Hemostasis
• Anemia and Other Red Cell Disorders
• Cellular Therapy
• Bone Marrow Failure Syndromes
• Hematopoiesis/Stem Cell Biology
• Chronic Myeloid Leukemia
• Hematopoietic Stem Cell Transplantation
• Myeloproliferative Neoplasm
• Laboratory Hematology
• Histiocytosis and Other Dendritic Cell Neoplasm
• Quality of Life
• Transfusion Medicine
• Others

Welcome Message

On behalf of the Organizing Committee, it is our great pleasure to invite you to participate in the 2025 Korean Society of Hematology (KSH) International Conference & 66th Annual Meeting, which will take place from March 27 to 29, 2025, in Seoul, Korea.

Since its inception in 2018, the ICKSH Congress has served as a premier platform for sharing the latest advancements and fostering discussions on crucial and emerging issues in the field of Hematology. Each year, it attracts world-renowned experts who engage in dynamic debates and collaboration.

This year’s program promises to cover a wide range of topics, including benign hematologic diseases, various hematologic malignancies, coagulation/thrombosis disorders, and transfusion medicine. Attendees can expect a diverse offering of plenary lectures, presidential symposium, scientific symposia, joint and educational sessions designed to address the most pressing challenges in our field.